ASC-63
N/A
Report date: 2022/01/17 11:35:07
NME
Base Information
Drug NameASC-63
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAscletis Pharma Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A